Author:
Trusheim Mark R.,Burgess Breon,Hu Sean Xinghua,Long Theresa,Averbuch Steven D.,Flynn Aiden A.,Lieftucht Alfons,Mazumder Abhijit,Milloy Judy,Shaw Peter M.,Swank David,Wang Jian,Berndt Ernst R.,Goodsaid Federico,Palmer Michael C.
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference53 articles.
1. Trusheim, M., Berndt, E. & Douglas, F. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nature Rev. Drug Discov. 6, 287–293 (2007).
2. Hu, S. X. et al. Pharmacogenomics and personalized medicine: mapping of future value creation. BioTechniques 39, S1–S6 (2005).
3. Aspinall, M. G. & Hamermesh, R. G. Realizing the promise of personalized medicine. Harvard Bus. Rev. 85, 108–117 (2007).
4. Phillips, K. A. et al. Diagnostics and biomarker development: priming the pipeline. Nature Rev. Drug Discov. 5, 463–469 (2006).
5. US Food and Drug Administration. Table of Pharmacogenomic Biomarkers in Drug Labels. FDA website [online] , (2011).
Cited by
87 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献